LEGNANI, LAURA
LEGNANI, LAURA
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
PCSK9 inhibitors: a patent review 2018-2023
2024 E.M.A. Fassi, A. Citarella, M. Albani, E.G. Milano, L. Legnani, C. Lammi, A. Silvani, G. Grazioso
Multivalent calix[4]arene-based mannosylated dendrons as new FimH ligands and inhibitors
2023 A. Palmioli, L. Moretti, C.A. Vezzoni, L. Legnani, P. Sperandeo, L. Baldini, F. Sansone, C. Airoldi, A. Casnati
Structure-based drug design, synthesis and biological assays of P. falciparum Atg3-Atg8 protein-protein interaction inhibitors
2018 S. Villa, L. Legnani, D. Colombo, A. Gelain, C. Lammi, D. Bongiorno, D.P. Ilboudo, K.E. Mcgee, J. Bosch, G. Grazioso
6-Sulphonate glucose derivatives as potential kinase inhibitors
2014 L. Cipolla, L. Gabrielli, M. Vetro, D. Colombo, L. Legnani, B. Costa, P. Perego, I. Calloni
Modeling, synthesis and NMR characterization of novel chimera compounds targeting STAT3
2014 S. Dell'Orto, D. Masciocchi, S. Villa, F. Meneghetti, G. Celentano, D. Barlocco, D. Colombo, L. Legnani, L.A. Toma, Y.J. Jeon, B. Kwon, A. Asai, A. Gelain
Roseic acid and roseolactones A and B, Furan-Cucurbitane Triterpenes from Russula aurora and R. minutula (Basidiomycota)
2014 M. Clericuzio, G. Vidari, C. Cassino, L. Legnani, L. Toma
Synthesis of anionic glycolipid fluorescent probes targeting protein kinase B (AKT)
2014 D. Colombo, F. Compostella, L. Legnani, F. Ronchetti, P. Perego, N. Arrighetti, L. Cipolla, B. Costa, M. Vetro
A full conformational characterization of antiandrogen cortexolone- 17α-propionate and related compounds through theoretical calculations and nuclear magnetic resonance spectroscopy
2014 P. Ferraboschi, L. Legnani, G. Celasco, L. Moro, L. Ragonesi, D. Colombo
Synthesis and evaluation of a new anionic glycoglycerolipids targeting protein kinase B (AKT)
2013 D. Colombo, F. Ronchetti, F. Compostella, L. Legnani, N. Aldrighetti, V.L.M. Vetro
Synthesis, structure–activity relationships andstereochemical investigations of new tricyclic pyridazinone derivatives as potential STAT3 inhibitors
2013 D. Masciocchi, A. Gelain, F. Porta, F. Meneghetti, A. Pedretti, G. Celentano, D. Barlocco, L. Legnani, L. Toma, B.M. Kwon, A. Asai, S. Villa
Synthesis and molecular dynamic simulations of a Vi antigen sulfated analogue
2013 F. Compostella, L. Legnani, C. Romano', M. Vetro, L. Toma
Crystallographic, spectroscopic, and theoretical investigation of the efficiently separated 21R and 21S-diastereoisomers of argatroban
2013 P. Ferraboschi, D. Colombo, L. Legnani, L. Toma, P. Grisenti, G. Vistoli, F. Meneghetti
New anionic glycoglicerolipids targeting protein kinase B (Akt)
2013 M. Vetro, D. Colombo, L. Legnani, F. Compostella, F. Ronchetti
From Cyclopentadiene to Isoxazoline-Carbocyclic Nucleosides; Synthesis of Highly Active Inhibitors of Influenza A Virus H1N1
2013 P. Quadrelli, M. Mella, L. Legnani, D. Al Saad
Exploring scaffolds to discover new STAT3 inhibitors, as novel anticancer agents.
2012 S. Villa, D. Masciocchi, A. Gelain, S. Dell'Orto, F. Meneghetti, A. Pedretti, D. Barlocco, L. Legnani, L. Yoma, B._.M. Kwon, S. Nakano, A. Asai
A 2,3-carbamate-bearing allyl galactosamine donor for the synthesis of repeating alfa-(1 4)-linked galactosamine units
2012 M. Vetro, L. Legnani, L. Toma, F. Ronchetti, F. Compostella
Merged structures as new STAT3 inhibitors: the chimera compounds
2012 A. Gelain, D. Masciocchi, S. Villa, S. Dell’Orto, F. Meneghetti, A. Pedretti, D. Barlocco, L. Legnani, L. Toma, B. Kwon, S. Nakano, A. Asai
Molecular dynamics simulations of the Salmonella typhi Vi antigenic polysaccharide and effects of the introduction of a zwitterionic motif
2011 L. Legnani, F. Compostella, G. Grazioso, F. Marinone Albini, L. Toma
SAR studies on a novel series of ACAT inhibitors
2006 A. Gelain, D. Barlocco, B.-. Kwon, T.-. Jeong, K.-. Im, L. Legnani, L. Toma